グロービング株式会社 Logo

グロービング株式会社

Accelerates business growth via strategic consulting, AI implementation, and proprietary SaaS.

277A | T

Overview

Corporate Details

ISIN(s):
JP3274430002
LEI:
Country:
Japan
Address:
港区南青山3丁目1−34
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Globe-ing Inc. is a professional services firm that accelerates client business growth by integrating strategic consulting with digital transformation and AI/technology implementation. The company's core services include strategic consulting (spanning Business, Operation, and Ecosystem strategies), an executive advisory service, and its proprietary 'Octagon Service,' a suite of cloud-based products that industrializes proven consulting methodologies into SaaS solutions. Globe-ing's competitive edge is its unique 'insider with an external perspective' approach, embedding deeply within client organizations to ensure strategies are both advanced and culturally feasible. By employing seasoned professionals from top-tier consulting firms and corporations, the firm guides clients through complex transformations with the ultimate goal of fostering their long-term autonomy and self-sufficiency.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 06:10
Registration Form
確認書
Japanese 8.8 KB
2025-08-28 06:08
Registration Form
有価証券報告書-第10期(2024/06/01-2025/05/31)
Japanese 1.6 MB
2025-08-13 08:26
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2025-01-14 07:31
Regulatory News Service
確認書
Japanese 8.9 KB
2025-01-14 07:30
Interim Report
半期報告書-第10期(2024/06/01-2025/05/31)
Japanese 217.5 KB
2024-11-21 07:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.0 MB
2024-11-13 07:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.0 MB
2024-10-24 08:39
Registration Form
有価証券届出書(新規公開時)
Japanese 3.8 MB

Automate Your Workflow. Get a real-time feed of all グロービング株式会社 filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for グロービング株式会社

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for グロービング株式会社 via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.